Patents by Inventor Daniel Alam
Daniel Alam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11956855Abstract: A system enables a home operator to establish an automated monitoring process which identifies outage events on competitor wireless networks (e.g., peer operators) operating in the same geographies as home operator. The home operator then is able to selectively offer, in near real-time, to open roaming to the peer operator, or implement roaming automatically based on predefined and mutually agreed upon rule sets. The monitoring process may observe non-customer attach request volumes in order to identify outage events on competitor wireless networks.Type: GrantFiled: October 12, 2021Date of Patent: April 9, 2024Assignees: AT&T Intellectual Property I, L.P., AT&T Mobility II LLCInventors: Robert S. Klein, Mohammed Yousuffi, Nathan Stowell, Senthil Raj Dhandapani, Daniel Powell, Iftekhar Alam, Slawomir Stawiarski, William Turczyn, Ngwane Maina
-
Publication number: 20240083292Abstract: Electric vehicle charging systems and methods are provided, which include an energy storage unit and a docking station sized to accommodate the energy storage unit within the docking station in a docked position. The docking station includes an energy storage docking receptacle to operatively couple the energy storage unit to the docking station in the docked position. The electric vehicle charging system facilitates charging an electric vehicle battery.Type: ApplicationFiled: September 13, 2023Publication date: March 14, 2024Applicant: SparkCharge, Inc.Inventors: Rifat Alam SIDDIQUE, Daniel JANOWIEC
-
Publication number: 20240083293Abstract: Modular electric vehicle charging systems and methods are provided which include a swappable energy storage unit and a charger unit. The swappable energy storage unit and the charger unit are operatively coupled via a detachable cable assembly, and at least one control is provided to control charging of an electric vehicle battery by the modular electric vehicle charging system.Type: ApplicationFiled: September 13, 2023Publication date: March 14, 2024Applicant: SparkCharge, Inc.Inventors: Rifat Alam SIDDIQUE, Daniel JANOWIEC
-
Patent number: 8207262Abstract: A dihydroxyphenyl cross-linked macromolecular network is provided that is useful in artificial tissue and tissue engineering applications, particularly to provide a synthetic macromolecular network for a wide variety of tissue types. In particular, artificial or synthetic cartilage, vocal cord material, vitreous material, soft tissue material and mitral valve material are described. In an embodiment, the network is composed of tyramine-substituted and cross-linked hyaluronan molecules, wherein cross-linking is achieved via peroxidase-mediated dityramine-linkages that can be performed in vivo. The dityramine bonds provide a stable, coherent hyaluronan-based hydrogel with desired physical properties.Type: GrantFiled: September 15, 2008Date of Patent: June 26, 2012Assignee: The Cleveland Clinic FoundationInventors: Anthony Calabro, Lee Akst, Daniel Alam, James Chan, Aniq B. Darr, Kiyotaka Fukamachi, Richard A. Gross, David Haynes, Keiji Kamohara, Daniel P. Knott, Hilel Lewis, Alex Melamud, Anthony Miniaci, Marshall Strome
-
Publication number: 20090143766Abstract: A dihydroxyphenyl cross-linked macromolecular network is provided that is useful in artificial tissue and tissue engineering applications, particularly to provide a synthetic macromolecular network for a wide variety of tissue types. In particular, artificial or synthetic cartilage, vocal cord material, vitreous material, soft tissue material and mitral valve material are described. In an embodiment, the network is composed of tyramine-substituted and cross-linked hyaluronan molecules, wherein cross-linking is achieved via peroxidase-mediated dityramine-linkages that can be performed in vivo. The dityramine bonds provide a stable, coherent hyaluronan-based hydrogel with desired physical properties.Type: ApplicationFiled: January 29, 2009Publication date: June 4, 2009Applicant: The Cleveland Clinic FoundationInventors: Anthony Calabro, Lee Akst, Daniel Alam, James Chan, Aniq B. Darr, Kiyotaka Fukumachi, Richard A. Gross, David Haynes, Keiji Kamohara, Daniel P. Knott, Hilel Lewis, Alex Melamud, Anthony Miniaci, Marshall Strome
-
Publication number: 20090142309Abstract: A dihydroxyphenyl cross-linked macromolecular network is provided that is useful in artificial tissue and tissue engineering applications, particularly to provide a synthetic macromolecular network for a wide variety of tissue types. In particular, artificial or synthetic cartilage, vocal cord material, vitreous material, soft tissue material and mitral valve material are described. In an embodiment, the network is composed of tyramine-substituted and cross-linked hyaluronan molecules, wherein cross-linking is achieved via peroxidase-mediated dityramine-linkages that can be performed in vivo. The dityramine bonds provide a stable, coherent hyaluronan-based hydrogel with desired physical properties.Type: ApplicationFiled: January 29, 2009Publication date: June 4, 2009Applicant: The Cleveland Clinic FoundationInventors: Anthony Calabro, Lee Akst, Daniel Alam, James Chan, Aniq B. Darr, Kiyotaka Fukamachi, Richard A. Gross, David Haynes, Keiji Kamohara, Daniel P. Knott, Hilel Lewis, Alex Melamud, Anthony Miniaci, Marshall Strome
-
Publication number: 20090042294Abstract: A dihydroxyphenyl cross-linked macromolecular network is provided that is useful in artificial tissue and tissue engineering applications, particularly to provide a synthetic macromolecular network for a wide variety of tissue types. In particular, artificial or synthetic cartilage, vocal cord material, vitreous material, soft tissue material and mitral valve material are described. In an embodiment, the network is composed of tyramine-substituted and cross-linked hyaluronan molecules, wherein cross-linking is achieved via peroxidase-mediated dityramine-linkages that can be performed in vivo. The dityramine bonds provide a stable, coherent hyaluronan-based hydrogel with desired physical properties.Type: ApplicationFiled: September 15, 2008Publication date: February 12, 2009Applicant: The Cleveland Clinic FoundationInventors: Anthony Calabro, Lee Akst, Daniel Alam, James Chan, Aniq B. Darr, Kiyotaka Fukamachi, Richard A. Gross, David Haynes, Keiji Kamohara, Daniel P. Knott, Hilel Lewis, Alex Melamud, Anthony Miniaci, Marshall Strome
-
Patent number: 7465766Abstract: A dihydroxyphenyl cross-linked macromolecular network is provided that is useful in artificial tissue and tissue engineering applications, particularly to provide a synthetic, implantable tissue matrix material for a wide variety of tissue types. In particular, artificial or synthetic cartilage, vocal cord material, vitreous material, soft tissue material and mitral valve material are described. In an embodiment, the network is composed of tyramine-substituted and cross-linked hyaluronan molecules, wherein cross-linking is achieved via peroxidase-mediated dityramine-linkages that can be performed in vivo. The dityramine bonds provide a stable, coherent hyaluronan-based hydrogel with desired physical properties.Type: GrantFiled: July 7, 2005Date of Patent: December 16, 2008Assignee: The Cleveland Clinic FoundationInventors: Anthony Calabro, Lee Akst, Daniel Alam, James Chan, Aniq B. Darr, Kiyotaka Fukamachi, Richard A. Gross, David Haynes, Keiji Kamohara, Daniel P. Knott, Hilel Lewis, Alex Melamud, Anthony Miniaci, Marshall Strome
-
Publication number: 20060084759Abstract: A dihydroxyphenyl cross-linked macromolecular network is provided that is useful in artificial tissue and tissue engineering applications, particularly to provide a synthetic, implantable tissue matrix material for a wide variety of tissue types. In particular, artificial or synthetic cartilage, vocal cord material, vitreous material, soft tissue material and mitral valve material are described. In an embodiment, the network is composed of tyramine-substituted and cross-linked hyaluronan molecules, wherein cross-linking is achieved via peroxidase-mediated dityramine-linkages that can be performed in vivo. The dityramine bonds provide a stable, coherent hyaluronan-based hydrogel with desired physical properties.Type: ApplicationFiled: July 7, 2005Publication date: April 20, 2006Applicant: The Cleveland Clinic FoundationInventors: Anthony Calabro, Lee Akst, Daniel Alam, James Chan, Aniq Darr, Kiyotaka Fukamachi, Richard Gross, David Haynes, Keiji Kamohara, Daniel Knott, Hilel Lewis, Alex Melamud, Anthony Miniaci, Marshall Strome